ANDA 75425, held by Watson Labs Teva. Cimetidine.
As of Nov 14, 2026, ANDA 75425 (Cimetidine), held by Watson Labs Teva, was first approved by FDA on Jul 29, 1999, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jul 29, 1999 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Cimetidine200MG ยท tablet;oral | Cimetidine | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
